Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

Saved in:
Bibliographic Details
Title: Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.
Authors: David S; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Kohlenberg A; European Centre for Disease Prevention and Control, Solna, Sweden. Electronic address: anke.kohlenberg@ecdc.europa.eu., Yeats C; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Abu-Dahab K; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Albiger B; European Centre for Disease Prevention and Control, Solna, Sweden., Alikhan NF; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Alm E; European Centre for Disease Prevention and Control, Solna, Sweden., Byfors S; Public Health Agency of Sweden, Solna, Sweden., Couto N; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Diaz Caballero J; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Giske CG; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden., Glasner C; University of Groningen, Groningen, Netherlands., Linkevicius M; European Centre for Disease Prevention and Control, Solna, Sweden., Matuschek E; European Committee on Antimicrobial Susceptibility Testing Development Laboratory, Växjö, Sweden., Palm D; European Centre for Disease Prevention and Control, Solna, Sweden., Svartström O; European Centre for Disease Prevention and Control, Solna, Sweden., Grundmann H; Institute for Infection Prevention and Hospital Epidemiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Struelens MJ; Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium., Tegmark Wisell K; Public Health Agency of Sweden, Solna, Sweden., Monnet DL; European Centre for Disease Prevention and Control, Solna, Sweden., Fröding I; Public Health Agency of Sweden, Solna, Sweden; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden., Aanensen DM; Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Brolund A; Public Health Agency of Sweden, Solna, Sweden.
Corporate Authors: EURGen-Net CCRE Survey Working Group
Source: The Lancet. Microbe [Lancet Microbe] 2026 Jun; Vol. 7 (6), pp. 101321. Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-5247
DOI:10.1016/j.lanmic.2025.101321